CD8A and neoplasm: The results of the study concluded that the combination therapy produced 5.9- and 4.0-fold increases in infiltration of CD3+ immune cells and CD8+ T cells, respectively, in post-treatment tumor biopsies compared to pre-treatment samples [66].